Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$32.9M Hold
90,739
5.54% 3
2026
Q1
$31.9M Buy
90,739
+200
+0.2% +$71.3K 6.12% 1
2025
Q4
$29.6M Sell
90,539
-300
-0.3% -$95.2K 5.66% 3
2025
Q3
$25.6M Buy
90,839
+100
+0.1% +$29K 5.07% 4
2025
Q2
$25.3M Buy
90,739
+100
+0.1% +$28.3K 5.42% 3
2025
Q1
$28.2M Sell
90,639
-5,912
-6% -$1.75M 6.7% 1
2024
Q4
$25.2M Sell
96,551
-120
-0.1% -$35.6K 3.95% 4
2024
Q3
$31.1M Buy
96,671
+121
+0.1% +$39.6K 4.97% 4
2024
Q2
$30.2M Buy
96,550
+344
+0.4% +$101K 5.3% 4
2024
Q1
$27.4M Buy
96,206
+311
+0.3% +$91K 5.09% 4
2023
Q4
$27.6M Buy
95,895
+1,485
+2% +$405K 5.95% 2
2023
Q3
$25.4M Buy
94,410
+612
+0.7% +$153K 6.26% 1
2023
Q2
$20.8M Buy
93,798
+225
+0.2% +$52.2K 5.15% 4
2023
Q1
$22.6M Sell
93,573
-130
-0.1% -$31.9K 5.75% 3
2022
Q4
$24.6M Sell
93,703
-199
-0.2% -$53.3K 6.77% 1
2022
Q3
$21.2M Buy
93,902
+438
+0.5% +$106K 5.94% 1
2022
Q2
$22.7M Sell
93,464
-1,031
-1% -$253K 5.85% 2
2022
Q1
$22.9M Sell
94,495
-6,307
-6% -$1.45M 5.38% 4
2021
Q4
$24.3M Buy
+100,802
New +$21.3M 5.73% 4

Other funds holding AMGN

JMAC Enterprises's AMGN Position: Q2 2026 in Review

JMAC Enterprises held its Amgen (AMGN) position steady in Q2 2026 at 90,739 shares worth $32.9M. The position accounts for 5.54% of the portfolio, ranked #3.

JMAC Enterprises first reported a position in AMGN in Q4 2021 and has held it in 19 quarters since. 1,221 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • JMAC Enterprises held 90,739 shares of Amgen worth $32.9M as of Q2 2026.
  • JMAC Enterprises left its Amgen share count unchanged in Q2 2026.
  • Amgen made up 5.54% of JMAC Enterprises's portfolio in Q2 2026, its #3 holding.
  • JMAC Enterprises first reported a position in Amgen in Q4 2021 and has held it in 19 quarters since.
  • 1,221 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on JMAC Enterprises's 13F filing for Q2 2026, filed 28 Jul 2026.